MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 355 filers reported holding MEDIVATION INC in Q3 2015. The put-call ratio across all filers is 0.57 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $161,319,000 | +79.7% | 2,675,286 | +37.0% | 0.09% | +81.2% |
| Q1 2016 | $89,790,000 | -3.7% | 1,952,808 | +1.3% | 0.05% | +2.1% |
| Q4 2015 | $93,229,000 | -1.4% | 1,928,608 | -13.3% | 0.05% | 0.0% |
| Q3 2015 | $94,542,000 | -55.0% | 2,224,508 | +20.8% | 0.05% | -50.5% |
| Q2 2015 | $210,245,000 | -25.5% | 1,841,024 | -15.8% | 0.10% | -25.8% |
| Q1 2015 | $282,172,000 | -4.3% | 2,186,215 | -26.1% | 0.13% | -4.5% |
| Q4 2014 | $294,847,000 | -7.5% | 2,959,987 | -8.2% | 0.13% | -7.6% |
| Q3 2014 | $318,624,000 | -10.5% | 3,222,697 | -30.2% | 0.14% | -7.6% |
| Q2 2014 | $355,887,000 | +24.9% | 4,617,189 | +4.3% | 0.16% | +16.3% |
| Q1 2014 | $284,896,000 | +23.1% | 4,425,923 | +22.0% | 0.14% | +19.5% |
| Q4 2013 | $231,513,000 | +17.2% | 3,627,610 | +10.0% | 0.11% | +7.6% |
| Q3 2013 | $197,614,000 | +55.9% | 3,296,870 | +28.0% | 0.10% | +45.8% |
| Q2 2013 | $126,759,000 | – | 2,576,391 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,484,101 | $148,897,000 | 79.45% |
| BB BIOTECH AG | 1,449,706 | $86,895,000 | 4.73% |
| SECTORAL ASSET MANAGEMENT INC | 1,013,529 | $60,751,000 | 2.92% |
| Orbimed Advisors | 2,284,500 | $136,933,000 | 2.44% |
| Archipel Asset Management AB | 191,016 | $11,449,000 | 2.35% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 147,060 | $8,815,000 | 1.43% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 450,000 | $26,973,000 | 1.32% |
| QVT Financial LP | 305,128 | $18,289,000 | 1.24% |
| Bain Capital Public Equity Management, LLC | 825,687 | $49,492,000 | 1.24% |
| Tradeworx Inc. | 44,484 | $2,666,000 | 1.22% |